home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

How EGFR Promotes Skin Cancer

  July, 10 2008 8:17
your information resource in human molecular genetics

Scientists have pinpointed the molecular mechanisms underlying tumour response to EGFR -- a protein that boosts the development of skin cancer, and an important target for cancer therapy.

Epidermal growth factor receptors (EGFR) stimulate skin cells called keratinocytes to multiply while simultaneously stopping them from becoming more specialized. The overall effect encourages tumours in skin cancer to develop. A paper published online in Nature Cell Biology reveals that EGFR wields these functions in skin cancer by preventing expression of Notch1, a gene essential for tumour development.

Notch1 gene expression and activity are significantly lower in keratinocyte cancer cell lines and tumours. When looking for small molecules that may activate Notch protein signalling, G. Paolo Dotto and co-authors found that EGFR is a major negative regulator of Notch1 gene expression in human keratinocytes and skin cancers. By analysing this mechanism in a mouse model of EGFR-dependent skin cancer, they also showed that EGFR stops expression of Notch1 by blocking the tumour suppressor gene p53.

EGFR is an important target of cancer therapy and several selective EGFR inhibitors have now been approved for clinical use. These findings provide further understanding of the molecular mechanisms underlying the tumour response to EGFR inhibition.

Author contact:

G. Paolo Dotto (Massachusetts General Hospital, Charlestown, MA, USA)
E-mail: gdotto@partners.org

Abstract available online.

(C) Nature Cell Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.